​

Funding Round

Series E - ROX Medical

Series E - ROX Medical

Investment Firm

Overview

ROX Medical is focused on the development of innovative devices for the treatment of chronic obstructive pulmonary disease.

Announced Date

Sep 06, 2016

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

Novartis Venture Fund

Novartis Venture Fund

Novartis Venture Fund is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Participant Investors

4

Investor Name
Participant InvestorApple Tree Partners
Participant InvestorNovartis Venture Fund
Participant InvestorDomain Associates
Participant InvestorVersant Ventures

Round Details and Background

ROX Medical raised $40000000 on 2016-09-06 in Series E

ROX Medical is focused on the development of innovative devices for the treatment of chronic obstructive pulmonary disease.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 21, 2004
Series A - ROX Medical
2-3.6M
Sep 06, 2016
Series E - ROX Medical
4-40.0M
Jul 22, 2011
Debt Financing - ROX Medical
-4.0M
Sep 06, 2012
Series D - ROX Medical
2-6.0M

Recent Activity

There is no recent news or activity for this profile.